Ovarian epithelial cancer

• A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Pending
  2024-518326-32-00 7 "Patients with advanced solid malignancies that have progress"
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Pending
  2025-523232-39-00 1 "Advanced Solid Tumors"
• AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting
  2025-520466-22-00 5 2026-04-29 "Advanced Platinum-resistant Epithelial Ovarian Cancer"
• A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications Recruiting
  2023-506227-29-00 3 2024-08-30 "locally advanced or metastatic solid tumors"
• Mirvetuximab soravtansine in combination with bevacizumab for the maintenance treatment of adult patients with FRα-high recurrent platinum-s … Recruiting
  2022-501606-35-01 11 2024-02-21 "Platinum-sensitive epithelial ovarian, fallopian tube, or pr"
• Evaluation of epithelial ovarian, primary peritoneal, or fallopian tube cancer treatment in first recurrance using platinum-based chemothera … Recruiting
  2022-501220-14-00 4 2023-10-17 "epithelial ovarian, primary peritoneal, or fallopian tube ca"
• A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known t … Recruiting
  2025-522613-26-00 7 2026-03-13 "Advanced Solid Cancers"
• A Phase 1 Study for ZW191 in Participants with Solid Tumors Recruiting
  2024-512299-37-00 1 2026-02-18 "Advanced solid tumors"
• A study to evaluate dosing schedules of mirvetuximab soravtansine in patients with epithelial ovarian, primary peritoneal, or fallopian tube … Recruiting
  2024-517184-23-00 4 2025-10-16 "platinum-resistant advanced high-grade epithelial ovarian, p"
• A Phase 1/2, Multicenter, Open Label, Dose Escalation and Dose Expansion Study of JK06, a 5T4 Antibody Drug Conjugate, in Patients with Unre … Recruiting
  2024-512421-92-00 7 2025-10-14 "Unresectable, Locally Advanced or Metastatic Cancer"
• SALVOVAR trial: A pragmatic randomized phase III trial to assess the utility of adjusting chemotherapy dose & dosing schedule with the SALVa … Recruiting
  2023-508260-30-01 5 2024-07-30 "Patients with poor prognostic OVARian cancers based on the t"
• A phase 1/2 open-label, multicenter study to assess the safety, pharmacokinetics and anti-tumor activity of GTAEXS617 in patients with advan … Recruiting
  2023-508227-13-00 7 2023-06-19 "Advanced solid tumors"
• MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer Recruiting
  2024-511219-78-00 5 2023-02-28 "epithelial ovarian cancer"
• First trial in humans testing the safety and efficacy of IMGN151 in women with recurrent gynaecological cancers Recruitment ended
  2023-506842-22-00 7 2025-05-19 "Recurrent endometrial cancer, recurrent epithelial ovarian, "
• Sentinel node detection with 99Tc albumin nanocolloid and indocianine green (ICG) in patients with epithelial ovarian cancer in early stages … Recruitment ended
  2023-505667-37-00 4 2023-10-06 "Epithelial ovarian cancer in early stages."
• A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tu … Recruitment ended
  2023-508194-89-00 4 2021-08-30 "Persistent or Recurrent Rare Epithelial Ovarian Tumors"
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Bas … Recruitment ended
  2024-516662-11-00 5 2018-11-23 "Ovarian epithelial cancer"
• A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors Ended
  2023-504824-24-00 3 2024-03-15 "Arm A: Diagnosed with uterine serous carcinoma (USC) Arm B: "
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 "Subjects with Aadvanced solid tumors for whom life-prolongin"
• A Study of SGN-B7H4V in Advanced Solid Tumors Ended
  2023-503389-22-00 1 2022-08-31 "Fallopian tube cancer"
• NIRAPK: Study of the relationships between pharmacokinetic properties (PK) and hematological toxicity of niraparib in ovarian cancer Ended
  2024-513856-14-00 6 2021-05-05 "Patients with high-grade serous epithelial ovarian, tubal or"
• A study to test Mirvetuximab Soravtansine (IMGN853) aganist doctor's choice of cancer medicines in women with advanced Epithelial Ovarian, P … Ended
  2024-516111-25-00 5 2020-11-09 "Platinum-Resistant Advanced High-Grade Epithelial Ovarian, P"
• First-line chemotherapy plus pembrolizumab and olaparib for BRCA nonmutated advanced EOC Ended
  2022-502124-52-00 5 2018-12-18 "Advanced epithelial ovarian cancer"

Showing 1–23 of 23 trials